Federated Hermes’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9
| Closed | -$47 | – | 2210 |
|
|
2024
Q3 | $47 | Sell |
9
-2,237,496
| -100% | -$11.7M | ﹤0.01% | 2025 |
|
|
2024
Q2 | $5.75M | Buy |
2,237,505
+672,803
| +43% | +$1.73M | 0.01% | 682 |
|
|
2024
Q1 | $7.7M | Buy |
1,564,702
+1,482,525
| +1,804% | +$7.29M | 0.02% | 623 |
|
|
2023
Q4 | $722K | Buy |
82,177
+43,389
| +112% | +$381K | ﹤0.01% | 1241 |
|
|
2023
Q3 | $445K | Buy |
38,788
+32,345
| +502% | +$371K | ﹤0.01% | 1377 |
|
|
2023
Q2 | $163K | Buy |
+6,443
| New | +$163K | ﹤0.01% | 1577 |
|
|
2023
Q1 | – | Sell |
-36,302
| Closed | -$670K | – | 2289 |
|
|
2022
Q4 | $670K | Sell |
36,302
-59,844
| -62% | -$1.1M | ﹤0.01% | 1263 |
|
|
2022
Q3 | $2.6M | Sell |
96,146
-25,254
| -21% | -$682K | 0.01% | 844 |
|
|
2022
Q2 | $1.68M | Buy |
+121,400
| New | +$1.68M | ﹤0.01% | 978 |
|
|
2018
Q4 | – | Sell |
-83,810
| Closed | -$2.08M | – | 2334 |
|
|
2018
Q3 | $2.08M | Buy |
83,810
+3,680
| +5% | +$91.5K | ﹤0.01% | 1072 |
|
|
2018
Q2 | $2.2M | Buy |
80,130
+21,600
| +37% | +$593K | 0.01% | 969 |
|
|
2018
Q1 | $1.8M | Buy |
58,530
+20,245
| +53% | +$623K | 0.01% | 1005 |
|
|
2017
Q4 | $1.37M | Sell |
38,285
-12,000
| -24% | -$429K | ﹤0.01% | 1101 |
|
|
2017
Q3 | $1.39M | Buy |
50,285
+30,285
| +151% | +$834K | ﹤0.01% | 1083 |
|
|
2017
Q2 | $528K | Sell |
20,000
-51
| -0.3% | -$1.35K | ﹤0.01% | 1365 |
|
|
2017
Q1 | $417K | Buy |
20,051
+51
| +0.3% | +$1.06K | ﹤0.01% | 1364 |
|
|
2016
Q4 | $414K | Hold |
20,000
| – | – | ﹤0.01% | 1354 |
|
|
2016
Q3 | $324K | Hold |
20,000
| – | – | ﹤0.01% | 1396 |
|
|
2016
Q2 | $272K | Hold |
20,000
| – | – | ﹤0.01% | 1422 |
|
|
2016
Q1 | $349K | Hold |
20,000
| – | – | ﹤0.01% | 1375 |
|
|
2015
Q4 | $683K | Buy |
+20,000
| New | +$683K | ﹤0.01% | 1203 |
|
|
2014
Q2 | – | Sell |
-49,490
| Closed | -$1.56M | – | 2005 |
|
|
2014
Q1 | $1.56M | Buy |
+49,490
| New | +$1.56M | 0.01% | 1038 |
|